RESEARCH PAPER
Changes in survival of colorectal cancer patients in Świętokrzyskie Province (Southern Poland) from the second half of the 1990s to the early 21st century – a population-based study
 
More details
Hide details
1
Department of Epidemiology and Cancer Control, Holy Cross Cancer Center, Poland
2
Faculty of Medical Sciences, School of Economics, Law and Medical Sciences, Poland
3
Department of Rehabilitation, Holy Cross Cancer Center, Poland
4
Faculty of Medicine and Health Sciences, Jan Kochanowski University, Poland
5
Surgical Oncology Clinic, Holy Cross Cancer Center, Poland
6
Department of Oncocardiology, Holy Cross Cancer Center Poland
7
Clinical Oncology Clinic, Holy Cross Cancer Center Poland
CORRESPONDING AUTHOR
Paweł Macek   

Department of Epidemiology and Cancer Control, Holycross Cancer Center, Artwińskiego 3, 25-734, Kielce, Poland
 
KEYWORDS
TOPICS
Ethics approval and informed consent. The study used data routinely collected in the Cancer Registry of the Holycross Cancer Center in Kielce. During the processing of epidemiological data, the authors complied with the provisions of the Act on Personal Data Protection (Journal of Laws, 2016. item 922).
ABSTRACT
Introduction and objectives:
For years, the increase in cancer incidence and deaths has constituted a significant health and social problem. Variation in the burden in cancers in different regions of the world requires constant monitoring of the epidemiological situation in this regard. Assessing survival in cancer patients is a valuable source of information for patients and physicians alike, as well as for politicians who have a direct impact on the shaping of health policy and health systems. The aim of the present study was to assess the changes in the 5-year relative survival of colorectal cancer patients during 1995–2014.

Material and methods:
The data of 8,970 patients with colorectal cancer in the years 1995–2014, 5,033 males and 3,937 females aged 67.5 ± 11.7 from Świętokrzyskie Cancer Registry were used. Cases were classified according to the topographical codes ICD-O-3: C18.0-C18.9, C19.9, C20.9, C21.0-C21.2, C21.8. The end of follow-up was fixed at 31 December 2014. Four five-year calendar periods were defined. In each calendar period, relative survival rates using the Ederer II method were estimated separately for males and females.

Results:
In 2010–2014 (against 1995–1999), the absolute increase in the 5-year relative survival in males and females with colon cancer was the highest and reached 9.8 percentage point (p.p.) and 9.6 p.p., respectively. Patterns of survival for both colon and rectal cancer patients according to gender and age were very similar.

Conclusions:
In 1995–2014, an increase in the value of relative survival rates of males and females with colorectal cancer was observed. Systematic increase in funding in health care was a chance for reducing the burden of colorectal cancer by more widespread and equal access of effective early detection and cancer treatment.

CONFLICT OF INTEREST
The authors report no conflict of interest whatsoever with regard to the present study.
 
REFERENCES (22)
1.
Fact Sheets by Cancer. http://globocan.iarc.fr/Pages/... (access 2017.05.25).
 
2.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013; 49(6):1374–403. https://doi: 10.1016/j.ejca.2012.12.027.
 
3.
Wojciechowska U, Olasek P, Czauderna K, Didkowska J. Nowotwory złośliwe w Polsce [Cancer in Poland in 2014] w 2014 roku. Krajowy Rejestr Nowotworów; 2016 in Polish.
 
4.
Korniluk J, Wcisło G, Nurzyński P, Stec R, Bodnar L, Obrocka B, et al. Epidemiology of colorectal cancer. Contemp Oncol Onkol. 2006; 10(3). https://www.termedia.pl/Epidem... (access 2006.04.12).
 
5.
Boyle T, Fritschi L, Platell C, Heyworth J. Lifestyle factors associated with survival after colorectal cancer diagnosis. Br J Cancer. 2013; 109(3):814–22. https://doi: 10.1038/bjc.2013.310.
 
6.
Kubiak A, Kycler W, Trojanowski M. Epidemiologia i profilaktyka raka jelita grubego w Polsce [Epidemiology and prevention of colorectal cancer in Poland]. Probl Hig Epidemiol. 2014; 95(3):636–42 in Polish.
 
7.
Krzakowski M, Warzocha K, Wysocki P. Onkologia kliniczna. T. II [Clinical Oncology. Vol. II]. Gdańsk: VIA MEDICA, 2015 in Polish.
 
8.
Pazdur R, Wagman L, Camphausen K, Hoskins W. Nowotwory złośliwe Postępowanie wielodyscyplinarne Leczenie systemowe, chirurgia, radioterapia. T. 1 [Cancers Multidisciplinary Systemic treatment, surgery, radiotherapy Vol. 1]. Lublin: CZELEJ Sp.z.o.o, 2012 in Polish.
 
9.
Jassem J, Krzakowski M. Nowotwory układu pokarmowego Praktyczny przewodnik dla lekarzy [Cancer of the digestive system Practical guide for physicians]. Gdańsk, VM Media, 2014 in Polish.
 
10.
Brenner H, Hakulinen T. Period versus cohort modeling of up-to-date cancer survival. Int J Cancer. 2008; 122(4):898–904.
 
11.
Jansen L, Hakulinen T, Brenner H. Study populations for period analyses of cancer survival. Br J Cancer. 2013; 108(3):699–707. https://doi: [10.1038/bjc.2013.14].
 
12.
Dickman P. Estimating and modelling relative survival using SAS http://www.pauldickman.com/rsm...(access 2016.12.27).
 
13.
Pokhrel A. Age-Standarization of Relative Survival Ratios for Cancer Patients. Academic Dissertation. University of Tampere, 2007.
 
14.
Age Standards for Survival – SEER Datasets. https://seer.cancer.gov/stdpop... (access 2017.05.22).
 
15.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). The Lancet. 2015; 385(9972):977–1010. https://doi: 10.1016/S0140–6736(14)62038–9.
 
16.
Cho H, Howlader N, Mariotto AB, Cronin KA. Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. https://surveillance.cancer.go... (access 2017.05.1).
 
17.
Gatta G, Capocaccia R, Sant M, Bell CMJ, Coebergh JWW, Damhuis R a. M, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut. 2000; 47(4):533–8. https://doi: 10.1136/gut.47.4.533.
 
18.
Ciccolallo L, Capocaccia R, Coleman MP, Berrino F, Coebergh JWW, Damhuis RAM, et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut. 2005; 54(2):268–73. https://doi: [10.1136/gut.2004.044214].
 
19.
Gatta G, Faivre J, Capocaccia R, Leon MP de. Survival of colorectal cancer patients in Europe during the period 1978–1989. Eur J Cancer. 1998; 34(14):2176–83. https://doi: [10.1136/gut.47.4.533].
 
20.
Baili P, Salvo FD, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, et al. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study. Eur J Cancer. 2015; 51(15):2120–9. https://doi: 10.1016/j.ejca.2015.07.025.
 
21.
NIK o profilaktyce zdrowotnej w systemie ochrony zdrowia – Najwyższa Izba Kontroli [NIK on health prevention in the health care system – Supreme Chamber of Control] https://www.nik.gov.pl/aktualn... (access 2018.01.25) in Polish.
 
22.
Verdecchia A, Guzzinati S, Francisci S, Angelis RD, Bray F, Allemani C, et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer. 2009; 45(6):1042–66. https://doi: 10.1016/j.ejca.2008.11.029.
 
eISSN:1898-2263
ISSN:1232-1966